Obesity-induced activation of SREBP2 and altered cholesterol metabolism in liver lead to hypercholesterolemia, resulting in excessive cholesterol uptake by NKT cells (Tang et al., 2022). The gene discussed is SREBF2; the disease is obesity disorder.